Clinical Trial

Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated July 15, 2024 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a multicenter, double-blind, placebo-controlled, randomized clinical trial that aims to evaluate the efficacy of probucol on the reduction of the risk of recurrent stroke in patients with symptomatic intracranial or extracranial arterial stenosis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-17; most recent amendment 2024-07-12.
Status change: Not Yet Recruiting → Recruiting 2024-07-12
Trial Details
NCT Number NCT06225752
Lead Sponsor First Affiliated Hospital of Wannan Medical College
Collaborators: Beijing Tiantan Hospital
Conditions Ischemic Stroke, TIA
Enrollment 5,452 participants
Start Date 2024-06-15
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-15